跳至主要内容
临床试验/TCTR20200410011
TCTR20200410011已完成2 期

An observational study: Clinical outcome of Er:YAG and Nd:YAG combination laser treatment for Meibomian gland dysfunction in patients with baggy eyelid

Bumrungrad International Hospital0 个研究点目标入组 43 人开始时间: 2020年4月10日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
43

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 90 Years(—)
性别
All

入选标准

  • 1.Age more than or equal to 18 years
  • 2. Clinially diagnosed with any stage of MGD with OSDI more than 12 or meibum quality score more than 1

排除标准

  • 1)Blindness or having one eye
  • 2)Having a history of glaucoma which required topical anti-glaucoma treatment
  • 3)Having a history of glaucoma and retinal intraocular surgery or lid surgery
  • 4)Having a history of ocular herpes within prior 3 months
  • 5)Having an active ocular inflammation or infection
  • 6)Having eyelid or ocular surface diseases
  • 7)Having systemic disease(s) causing dry eye / delayed wound healing
  • 8)Contact lens wearer
  • 9)Having abnormal scarring at laser treatment site
  • 10)Infection or inflammation of treatment area
  • 11)Prone to excessive sunlight exposure (tanned skin), which was darker than natural skin face tone within 2 weeks after the procedure [eg., outdoor occupation (farming, aerobic trainer), outdoor sport player, regular beach goers, etc.]
  • 12)Having a history of photosensitivity or use of photosensitizing medication
  • 13)Being pregnancy
  • 14)Having uncontrolled diabetes, heart and lung disease, or hypertension
  • 15)Known of cancer in the area to be treated
  • 16)Having autoimmune disorder(s)
  • 17)Having herpes simplex infection in the treatment area
  • 18)Having collagen, scarring and connective tissue disorders
  • 19)Having clotting disorders
  • 20)Having wound healing disorders
  • 21)Having or known of Epilepsy
  • 22)Having used Retin-A or similar products 3 days before and 7 days after treatment
  • 23)Having used Accutane (Roaccutane) within 6 months
  • 24)Having used Systemic antifungal, oral antifungal therapy, or isotretinoin within 6 months
  • 25)Ever used Gold therapy

研究者

发起方
Bumrungrad International Hospital

相似试验